A developing country perspective on vaccine-associated paralytic poliomyelitis

When the Expanded Programme on Immunization was established and oral poliovirus vaccine (OPV) was introduced for developing countries to use exclusively, national leaders of public health had no opportunity to make an informed choice between OPV and the inactivated poliovirus vaccine (IPV). Today, a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile nagusia:	John T. Jacob
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	The World Health Organization 2004-01-01
Saila:	Bulletin of the World Health Organization
Gaiak:	Poliovirus vaccine, Oral/adverse effects Poliomyelitis/epidemiology Poliomyelitis/chemically induced Poliovirus vaccine, Inactivated/therapeutic use Poliovirus vaccine, Inactivated/economics Poliovirus/drug effects Immunization programs Developing countries
Sarrera elektronikoa:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000100011
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!